Sunday, October 13, 2024 2:09:12 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent NRIX News
- Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer • GlobeNewswire Inc. • 01/22/2025 12:00:00 PM
- Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases • GlobeNewswire Inc. • 01/13/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/11/2025 02:33:13 AM
- Nurix Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 10:28:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2025 09:20:18 PM
- Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia • GlobeNewswire Inc. • 12/19/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 11:54:30 AM
- Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting • GlobeNewswire Inc. • 12/09/2024 11:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 11:00:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 09:36:23 PM
- Nurix Therapeutics Announces Webcast To Review New Data from Its Phase 1 Clinical Trial of BTK Degrader NX-5948 Presented at the 66th American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 12/02/2024 12:00:00 PM
- Nurix Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/25/2024 12:00:00 PM
- Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia • GlobeNewswire Inc. • 11/20/2024 09:00:00 PM
- Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 • GlobeNewswire Inc. • 11/17/2024 03:30:00 PM
- Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 11/05/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 10:48:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/04/2024 09:29:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 09:57:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 09:57:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:50:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:41:44 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/31/2024 08:36:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:12:54 PM
FEATURED Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • Jan 24, 2025 8:49 AM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM